Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Wen Xie
Capital Medical University
Beijing
China
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
83
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Glecaprevir/Pibrentasvir to Treat Chronic Hepatitis C Virus Infection in Asia: Two Multicentre, Phase 3 Studies – A Randomised, Double-Blind Study (VOYAGE-1) and an Open-Label, Single-Arm Study (VOYAGE-2)
Number of pages: 44
Posted: 17 Jan 2020
Lai Wei
,
Guiqiang Wang
,
Negar N. Alami
, Wen Xie,
Jeong Heo
,
Qing Xie
,
Mingxiang Zhang
,
Yoon Jun Kim
,
Seng Gee Lim
,
Linda M. Fredrick
,
Wenjing Lu
,
Wei Liu
,
Hari V. Kalluri
,
Preethi Krishnan
,
Rakesh Tripathi
,
Niloufar Mobashery
,
Margaret Burroughs
,
Armen Asatryan
,
Jidong Jia
and
Jinlin Hou
Peking University - People’s Hospital, Peking University - Department of Infectious Diseases, AbbVie, Capital Medical University, Pusan National University, Shanghai Jiao Tong University (SJTU) - Department of Infectious Diseases, Government of the People's Republic of China - Sixth People's Hospital of Shenyang, Seoul National University - Department of Internal Medicine, National University of Singapore (NUS), Yong Loo Lin School of Medicine, Department of Medicine, AbbVie, AbbVie, AbbVie, AbbVie, AbbVie, AbbVie, AbbVie, AbbVie, AbbVie, Capital Medical University and Southern Medical University - State Key Laboratory of Organ Failure Research
Downloads
83
(783,685)
View PDF
Download
Abstract:
Hepatitis C; glecaprevir/pibrentasvir; sustained virological response; Asia
Feedback